[Federal Register Volume 61, Number 214 (Monday, November 4, 1996)]
[Notices]
[Pages 56701-56702]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-28270]


-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES

Recombinant DNA Advisory Committee; Notice of Meeting

    Pursuant to Public Law 92-463, notice is hereby given of a meeting 
of the Recombinant DNA Advisory Committee on December 9, 1996. The 
meeting will be held at the National Institutes of Health, Building 
31C, 6th Floor, Conference Room 10, 9000 Rockville Pike, Bethesda, 
Maryland 20892, starting on December 9, 1996, at approximately 9 a.m., 
and will adjourn at approximately 5 p.m. The meeting will be open to 
the public to discuss Proposed Actions under the NIH Guidelines for 
Research Involving Recombinant DNA Molecules (59 FR 34496) and other 
matters to be considered by the Committee. The Proposed Actions to be 
discussed will follow this notice of meeting. Attendance by the public 
will be limited to space available. Members of the public wishing to 
speak at this meeting may be given such opportunity at the discretion 
of the Chair.
    Ms. Debra W. Knorr, Biotechnology Program Advisor, Office of 
Recombinant DNA Activities, National Institutes of Health, MSC 7010, 
6000 Executive Boulevard, Suite 302, Bethesda, Maryland 20892-7010, 
Phone (301) 496-9838, FAX (301) 496-9839, will provide materials to be 
discussed at this meeting, roster of committee members, and substantive 
program information. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should contact Ms. Knorr in advance of the meeting. A 
summary of the meeting will be available at a later date.
    OMB's ``Mandatory Information Requirements for Federal Assistance 
Program Announcements'' (45 FR 39592, June 11, 1980) requires a 
statement concerning the official government programs contained in the 
Catalog of Federal Domestic Assistance. Normally NIH lists in its 
announcements the number and title of affected individual programs for 
the guidance of the public. Because the guidance in this notice covers 
not only virtually every NIH program but also essentially every Federal 
research program in which DNA recombinant molecule techniques could be 
used, it has been determined not to be cost effective or in the public 
interest to attempt to list these programs.
    Such a list would likely require several additional pages. In 
addition, NIH could not be certain that every Federal program would be 
included as many Federal agencies, as well as private organizations, 
both national and

[[Page 56702]]

international, have elected to follow the NIH Guidelines. In lieu of 
the individual program listing, NIH invites readers to direct questions 
to the information address above about whether individual programs 
listed in the Catalog of Federal Domestic Assistance are affected.

    Dated: October 28, 1996.
Paula N. Hayes,
Acting Committee Management Officer, NIH.
[FR Doc. 96-28270 Filed 11-1-96; 8:45 am]
BILLING CODE 4140-01-M